🔥🐔 BizChicken 🐔🔥
Companies Similar to Relmada Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Sarepta Therapeutics, Inc.
EXONDYS 51, VYONDYS 53, AMONDYS 45, SRP-5051, SRP-9001, SRP-9003
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on developing RNA-targeted therapeutics and gene therapies for rare diseases, including treatments for Duchenne muscular dystrophy.
Contact | About | Leadership | About | About | About | Locations | About | About | About | About
Symbol: SRPT
Recent Price: $121.19
Industry: Biotechnology
CEO: Mr. Douglas S. Ingram Esq.
Sector: Healthcare
Employees: 1314
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 274 4000
Leadership
- Douglas S. Ingram, President and Chief Executive Officer
- Bilal Arif, Executive Vice President, Chief Technical Operations Officer
- Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer
- Ryan E. Brown, JD, Executive Vice President, Chief General Counsel
- Ian M. Estepan, Executive Vice President, Chief Financial Officer
- Dallan Murray, Executive Vice President, Chief Customer Officer
- Alison Nasisi, Executive Vice President, Chief People Officer
- Louise R. Rodino-Klapac, PhD, Executive Vice President, Head of R&D, Chief Scientific Officer
- Will Tilton, Senior Vice President, Head of Strategy, Chief of Staff
- M. Kathleen Behrens, PhD, Chairwoman
- Richard J. Barry,
- Kathryn Boor, PhD,
- Michael Chambers,
- Deirdre Connelly,
- Stephen L. Mayo, PhD,
- Claude Nicaise, MD,
- Hans Wigzell, MD, PhD,
- John C. Martin, PhD (In Memoriam),
- Annemieke Aartsma-Rus, PhD,
- Carsten Bönnemann, MD,
- Joy Cavagnaro, PhD, DABT, Fellow ATS,
- Kay Davies, PhD, DBE FMedSci FRS,
- Steven Gray, PhD,
- Angela J. Russell, DPhil,
Last updated: 2024-12-31
Amneal Pharmaceuticals, Inc.
Emverm, Rytary, Unithroid
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products across various dosage forms and therapeutic areas, operating through Generics, Specialty, and Av KARE segments.
Our Story | Our Story | Our Story | Our Story | About | About | Leadership | Leadership | Leadership | Locations | About | About | About | About | About | Awards | Contact | About | About | About | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: AMRX
Recent Price: $7.83
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Chirag K. Patel
Sector: Healthcare
Employees: 7850
Address: 400 Crossing Boulevard, Bridgewater, NJ 08807
Phone: 908 947 3120
Leadership
- Chirag Patel, President and Co-Chief Executive Officer
- Chintu Patel, Co-Chief Executive Officer
- Tasos Konidaris, Executive Vice President, Chief Financial Officer
- Nikita Shah, Executive Vice President, Chief Human Resources Officer
- Jason B. Daly, Esq., Senior Vice President, Chief Legal Officer & Corporate Secretary
- Gregory Sgammato, Senior Vice President, Corporate Development
- Andrew S. Boyer, Executive Vice President, Chief Commercial Officer – Generics
- Joe Renda, Senior Vice President, Chief Commercial Officer - Specialty
- Shyamakant Giri, President, India Business & Emerging Markets
- Sanjay Kumar Jain, PhD, Chief Quality Officer
- Srinivas Kone, PhD, Senior Vice President, Chief Scientific Officer – Generics
- Richard D’Souza, PhD, Senior Vice President, Specialty R&D
- Maryll W. Toufanian, Senior Vice President, Regulatory Strategy and Government Affairs
- Pranav Mehta, Senior Vice President, Strategic Sourcing & Supply Management
- Sandeep R. Raktate, President, Operations – India & Ireland
Last updated: 2024-12-31
Aquestive Therapeutics, Inc.
Sympazan, Suboxone, Zuplenz, Azstarys, Libervant, Exservan
Aquestive Therapeutics, Inc. is a pharmaceutical company committed to identifying, developing, and commercializing innovative products to address unmet medical needs, both in the U.S. and globally. It specializes in oral soluble film formulations for various treatments, including neurological conditions and opioid dependence.
Symbol: AQST
Recent Price: $3.52
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Daniel Barber
Sector: Healthcare
Employees: 135
Address: 30 Technology Drive, Warren, NJ 07059
Phone: 908 941 1900
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Cumberland Pharmaceuticals Inc.
Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex
Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.
Symbol: CPIX
Recent Price: $2.42
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. A. J. Kazimi MBA
Sector: Healthcare
Employees: 91
Address: 2525 West End Avenue, Nashville, TN 37203
Phone: 615 255 0068
Last updated: 2024-12-31
Curis, Inc.
Emavusertib
Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.
About | Management | Directors | About | About | Contact | Contact | Contact | About | Careers | Careers | Benefits | About | About | About | About | Jobs | About
Symbol: CRIS
Recent Price: $3.14
Industry: Biotechnology
CEO: Mr. James E. Dentzer
Sector: Healthcare
Employees: 49
Address: Building C, Lexington, MA 02421
Phone: 617 503 6500
Leadership
- Martyn D. Greenacre, Chair of the Board
- John Hohneker, M.D., Director
- Kenneth I. Kaitin, Ph.D., Director
- Anne E. Borgman, M.D., Director
- Marc Rubin, M.D., Director
- James Dentzer, Chief Executive Officer and Director
Last updated: 2024-12-31
Dermata Therapeutics, Inc.
DMT310
Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of pharmaceutical candidates for treating medical and aesthetic skin conditions. The company focuses on products such as DMT310 for acne, rosacea, and psoriasis, and DMT410 for hyperhidrosis and aesthetic conditions.
Symbol: DRMA
Recent Price: $1.34
Industry: Biotechnology
CEO: Mr. Gerald T. Proehl
Sector: Healthcare
Employees: 8
Address: 3525 Del Mar Heights Road, San Diego, CA 92130
Phone: 858 800 2543
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Minerva Neurosciences, Inc.
Roluperidone
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.
Symbol: NERV
Recent Price: $2.29
Industry: Biotechnology
CEO: Dr. Remy Luthringer Ph.D.
Sector: Healthcare
Employees: 9
Address: 1601 Trapelo Road, Waltham, MA 02451
Phone: 617 600 7373
Leadership
- Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
- Geoff Race, FCMA, MBA, President
- Michael Davidson, M.D., Chief Medical Officer
- Frederick Ahlholm, CPA, Chief Financial Officer
- Joseph Reilly, Senior Vice President and Chief Operating Officer
- Jay Saoud, PhD, Consultant
- Hans Peter Hasler, Board Member
- Jan van Heek, Board Member
- David Kupfer, MD, Board Member
- Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals
Last updated: 2024-12-31
Relay Therapeutics, Inc.
RLY-4008, RLY-2608, RLY-1971
Relay Therapeutics, Inc. is a clinical-stage company that focuses on precision medicine in oncology and genetic diseases by transforming the drug discovery process. Their leading products include small molecule inhibitors for advanced cancer treatment.
Symbol: RLAY
Recent Price: $4.18
Industry: Biotechnology
CEO: Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 323
Address: 399 Binney Street, Cambridge, MA 02139
Phone: 617 370 8837
Last updated: 2024-12-31
Entrada Therapeutics, Inc.
ENTR-601-44
Entrada Therapeutics, Inc. develops endosomal escape vehicle (EEV) therapeutics for treating neuromuscular diseases, with a lead product candidate ENTR-601-44 in preclinical trials for Duchenne muscular dystrophy and myotonic dystrophy type 1.
About | Contact | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About
Symbol: TRDA
Recent Price: $17.37
Industry: Biotechnology
CEO: Mr. Dipal Doshi
Sector: Healthcare
Employees: 168
Address: 6 Tide Street, Boston, MA 02210
Phone: 857 520 9158
Last updated: 2024-12-31
Avenue Therapeutics, Inc.
intravenous Tramadol
Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the acute/intensive care hospital setting. The company is advancing intravenous Tramadol, a synthetic dual-acting opioid, in Phase III clinical trials for post-operative acute pain treatment.
About | Leadership | Directors | About | Leadership | About | Contact | About | Contact | Contact | Careers | Leadership | Directors | About | About | Contact | About
Symbol: ATXI
Recent Price: $1.94
Industry: Biotechnology
CEO: Dr. Alexandra MacLean M.D.
Sector: Healthcare
Employees: 3
Address: 1140 Avenue of the America, New York, NY 10036
Phone: 781 652 4500
Leadership
- Jay Kranzler, MD, PhD, Chairman of the Board of Directors
- Alexandra MacLean, MD, Director
- David Jin, Interim Chief Financial Officer
- Scott A. Reines, MD, PhD, Interim Chief Medical Officer
- Michael Ryan, MS, Vice President of Clinical Operations and Program Management
- Alix MacLean, Chief Executive Officer
- Lindsay A. Rosenwald, MD, Director
- Neil Herskowitz, Director
- Curtis Oltmans, Director
- Faith Charles, Director
Last updated: 2024-12-31
Eagle Pharmaceuticals, Inc.
Ryanodex, Belrapzo, Bendeka, EP-4104, PEMFEXY, EA-114, Vasopressin
Eagle Pharmaceuticals, Inc. specializes in the development and commercialization of pharmaceutical products targeting diseases of the central nervous system, metabolic critical care, and oncology in the U.S. Notable products include Ryanodex for malignant hyperthermia, and oncology treatments Belrapzo and Bendeka.
Symbol: EGRX
Recent Price: $0.50
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Michael Graves
Sector: Healthcare
Employees: 134
Address: 50 Tice Boulevard, Woodcliff Lake, NJ 07677
Phone: 201 326 5300
Last updated: 2024-12-31
Madrigal Pharmaceuticals, Inc.
resmetirom
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.
Symbol: MDGL
Recent Price: $311.62
Industry: Biotechnology
CEO: Mr. William J. Sibold
Sector: Healthcare
Employees: 376
Address: Four Tower Bridge, West Conshohocken, PA 19428
Phone: 267 824 2827
Leadership
- BILL SIBOLD, Chief Executive Officer
- REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
- MARDI C. DIER, Chief Financial Officer
- CAROLE HUNTSMAN, Chief Commercial Officer
- CLINT WALLACE, Chief Human Resources Officer
- RONALD FILIPPO, Chief Information Officer
- STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
- SHANNON KELLEY, General Counsel
- MARK BARRETT, Chief Business Officer
- MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
- Julian C. Baker, Chairman and Director
- Kenneth M. Bate, Director
- Raymond Cheong, M.D., Ph.D., Director
- Fred Craves, Ph.D., Director
- James M. Daly, Director
- Paul A. Friedman, M.D., Director
- Richard S. Levy, M.D., Director
- Bill Sibold, Director, Chief Executive Officer
- Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
Last updated: 2024-12-31
Relmada Therapeutics, Inc.
Esmethadone (d-methadone, dextromethadone, REL-1017)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing products for central nervous system (CNS) diseases. Their lead product, Esmethadone, is in Phase 3 clinical trials for treating major depressive disorder.
Symbol: RLMD
Recent Price: $0.46
Industry: Biotechnology
CEO: Dr. Sergio Traversa M.B.A., Pharm.D.
Sector: Healthcare
Employees: 20
Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL 33134
Phone: 786 629 1376
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31